Literature DB >> 1587693

Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates.

G A Peyman1, M Conway, B Khoobehi, K Soike.   

Abstract

Experiments were conducted with biodegradable microspheres containing antimetabolites to assess the release of the drugs from the microspheres into the vitreous cavity of primates. Microspheres containing a mixture of radiolabeled and cold cytosine arabinoside (Ara-C) or 5-fluorouracil (5-FU) were prepared using a solvent evaporation process. The copolymers of poly (lactic) and poly (glycolic) acid (85:15) and drug was dissolved in a mixture of chloroform and acetone. The solutions were then emulsified in an aqueous solution of polyvinyl alcohol and stirred for 24 hours to evaporate the organic solvent. A 0.1 mL aliquot of a suspension of the microspheres was then injected into one eye of eight African Green monkeys. Half received 250 +/- 10 micrograms of Ara-C and the others 375 +/- 15 micrograms of 5-FU. The concentration in the vitreous was then measured by removing a 0.1 mL sample of vitreous at 1, 2, 4 and 11 days after injection. Both drugs released from microspheres were still detectable in the eye 11 days after injection and the clearance kinetics were similar for both drugs. The results indicate that the microspheres appear promising as a slow drug-delivery system for future investigations in conjunction with these and other antimetabolites suitable for the treatment of PVR.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587693     DOI: 10.1007/bf00918942

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  12 in total

1.  Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection.

Authors:  B Khoobehi; M O Stradtmann; G A Peyman; O M Aly
Journal:  Ophthalmic Surg       Date:  1991-03

2.  5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite.

Authors:  M Blumenkranz; E Hernandez; A Ophir; E W Norton
Journal:  Ophthalmology       Date:  1984-02       Impact factor: 12.079

3.  Evaluation of toxicity of intravitreal antineoplastic drugs.

Authors:  G A Peyman; D Greenberg; G A Fishman; R Fiscella; A Thomas
Journal:  Ophthalmic Surg       Date:  1984-05

4.  Changing concepts of failures after retinal detachment surgery.

Authors:  W F Rachal; T C Burton
Journal:  Arch Ophthalmol       Date:  1979-03

5.  Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.

Authors:  Y Tano; D Chandler; R Machemer
Journal:  Am J Ophthalmol       Date:  1980-12       Impact factor: 5.258

6.  In vitro evaluation of cellular inhibitory potential of various antineoplastic drugs and dexamethasone.

Authors:  R Fiscella; G A Peyman; J Elvart; B Yue
Journal:  Ophthalmic Surg       Date:  1985-04

7.  Inhibition of experimental intraocular proliferation with intravitreous 5-fluouracil. A transmission electron-microscopic study in rabbits.

Authors:  W Kulnig; S Binder; B Riss; C Skorpik
Journal:  Ophthalmologica       Date:  1984       Impact factor: 3.250

8.  Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo.

Authors:  P Wiedemann; N Sorgente; C Bekhor; R Patterson; T Tran; S J Ryan
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-05       Impact factor: 4.799

9.  Fluorouracil for the treatment of massive periretinal proliferation.

Authors:  M S Blumenkranz; A Ophir; A J Claflin; A Hajek
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258

10.  Clearance of intravitreal 3H-fluorouracil.

Authors:  J L Case; G A Peyman; A Barrada; R Hendricks; R Fiscella; M Hindi
Journal:  Ophthalmic Surg       Date:  1985-06
View more
  5 in total

Review 1.  New techniques for drug delivery to the posterior eye segment.

Authors:  Esther Eljarrat-Binstock; Jacob Pe'er; Abraham J Domb
Journal:  Pharm Res       Date:  2010-02-13       Impact factor: 4.200

2.  Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo.

Authors:  Haihua Zheng; Zhimin Wang; Peijuan Wang; Yaqin Liu; Zhaoxin Jiang; Qianying Gao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-27       Impact factor: 3.117

3.  Drug delivery to the posterior segment of the eye for pharmacologic therapy.

Authors:  Shalin S Shah; Lori Vidal Denham; Jasmine R Elison; Partha S Bhattacharjee; Christian Clement; Tashfin Huq; James M Hill
Journal:  Expert Rev Ophthalmol       Date:  2010-02-01

Review 4.  Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications.

Authors:  Blake A Booth; Lori Vidal Denham; Saadallah Bouhanik; Jean T Jacob; James M Hill
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

5.  Intravitreal Injections: A Historic Background.

Authors:  Gholam A Peyman
Journal:  J Ophthalmic Vis Res       Date:  2018 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.